A recent study indicates that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who end conventional diet and exercise regimens.
Published data in a prominent medical journal demonstrates that while obese people can lose substantial amounts of their body weight while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"People purchasing such drugs must be cognizant of the risk of fast weight regain when the treatment concludes," stated expert Dr. Susan Jebb.
That rate of regain suggests a reversion to original weight in about a year and a half.
Weighing Therapies
The research, which reviewed dozens of studies involving thousands of participants, compared the outcomes of GLP-1 agonists with conventional dieting.
Researchers note that people who lose weight through diet and exercise usually have a more gradual weight regain—approximately 100 grams monthly—once they finish.
Explaining the Rapid Rebound
Experts believe the mechanism of the injections accounts for the accelerated weight return.
GLP-1 drugs mimic a natural hormone called GLP-1, which controls hunger.
"Sustained high doses of the hormone concentrations several times higher than normal could lead to the body to produce less of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication results in hunger is uncontrolled, making binge eating far more likely."
An Ongoing Condition?
Medical guidelines recommend the injections for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.
Many experts contend that, considering the significant potential of relapse, the therapy should be considered life-long.
This view is echoed by pharmaceutical companies, who state that the results "emphasize the long-term character of obesity," comparing it to managing conditions like diabetes.
User Accounts
Individuals who have come off the medication report a intense return of hunger.
"It felt as if something that goes on and I was suddenly starving," recalled a patient.
This difficulty is exacerbated if users have not developed permanent dietary or behavioural changes during treatment.
Significant Interest
Recent estimates show that millions of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Use is more common among women compared to men.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
Finally, clinicians stress that while these medications are potent tools for weight loss, they are not a magic fix and long-term success hinges on combined lifestyle changes.
